Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1990 Oct;64(10):5160–5162. doi: 10.1128/jvi.64.10.5160-5162.1990

Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge.

E Malvoisin 1, F Wild 1
PMCID: PMC248009  PMID: 2398539

Abstract

To study the contribution of the measles virus fusion (F) protein in the immune response, anti-F monoclonal antibodies were prepared by using a vaccinia-measles virus F recombinant. In contrast to previously described anti-F monoclonal antibodies, these antibodies not only neutralized virus infectivity and inhibited fusion but also passively protected mice. Since these monoclonal antibodies recognize a configurational epitope, presentation of the antigen during infection may play an important role in the immune response. These factors are discussed in relation to vaccination.

Full text

PDF
5160

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abenes G., Kida H., Yanagawa R. Antigenic mapping and functional analysis of the F protein of Newcastle disease virus using monoclonal antibodies. Arch Virol. 1986;90(1-2):97–110. doi: 10.1007/BF01314148. [DOI] [PubMed] [Google Scholar]
  2. Beeler J. A., van Wyke Coelingh K. Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function. J Virol. 1989 Jul;63(7):2941–2950. doi: 10.1128/jvi.63.7.2941-2950.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Buckland R., Gerald C., Barker R., Wild T. F. Fusion glycoprotein of measles virus: nucleotide sequence of the gene and comparison with other paramyxoviruses. J Gen Virol. 1987 Jun;68(Pt 6):1695–1703. doi: 10.1099/0022-1317-68-6-1695. [DOI] [PubMed] [Google Scholar]
  4. Cherfas J. Hope for AIDS vaccines. Science. 1989 Oct 6;246(4926):23–24. doi: 10.1126/science.2781299. [DOI] [PubMed] [Google Scholar]
  5. Coelingh K. V., Tierney E. L. Identification of amino acids recognized by syncytium-inhibiting and neutralizing monoclonal antibodies to the human parainfluenza type 3 virus fusion protein. J Virol. 1989 Sep;63(9):3755–3760. doi: 10.1128/jvi.63.9.3755-3760.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Drillien R., Spehner D., Kirn A., Giraudon P., Buckland R., Wild F., Lecocq J. P. Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1252–1256. doi: 10.1073/pnas.85.4.1252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fulginiti V. A., Eller J. J., Downie A. W., Kempe C. H. Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. JAMA. 1967 Dec 18;202(12):1075–1080. doi: 10.1001/jama.202.12.1075. [DOI] [PubMed] [Google Scholar]
  8. Giraudon P., Wild T. F. Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology. 1985 Jul 15;144(1):46–58. doi: 10.1016/0042-6822(85)90303-4. [DOI] [PubMed] [Google Scholar]
  9. Giraudon P., Wild T. F. Monoclonal antibodies against measles virus. J Gen Virol. 1981 Jun;54(Pt 2):325–332. doi: 10.1099/0022-1317-54-2-325. [DOI] [PubMed] [Google Scholar]
  10. Homma M., Tashiro M., Konno H., Ohara Y., Hino M., Takase S. Isolation and characterization of subacute sclerosing panencephalitis virus (Yamagata-1 strain) from a brain autopsy. Microbiol Immunol. 1982;26(12):1195–1202. doi: 10.1111/j.1348-0421.1982.tb00270.x. [DOI] [PubMed] [Google Scholar]
  11. Kennedy H. E., Jones B. V., Tucker E. M., Ford N. J., Clarke S. W., Furze J., Thomas L. H., Stott E. J. Production and characterization of bovine monoclonal antibodies to respiratory syncytial virus. J Gen Virol. 1988 Dec;69(Pt 12):3023–3032. doi: 10.1099/0022-1317-69-12-3023. [DOI] [PubMed] [Google Scholar]
  12. Merz D. C., Scheid A., Choppin P. W. Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J Exp Med. 1980 Feb 1;151(2):275–288. doi: 10.1084/jem.151.2.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Neyt C., Geliebter J., Slaoui M., Morales D., Meulemans G., Burny A. Mutations located on both F1 and F2 subunits of the Newcastle disease virus fusion protein confer resistance to neutralization with monoclonal antibodies. J Virol. 1989 Feb;63(2):952–954. doi: 10.1128/jvi.63.2.952-954.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Norrby E., Enders-Ruckle G., Meulen V. Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus. J Infect Dis. 1975 Sep;132(3):262–269. doi: 10.1093/infdis/132.3.262. [DOI] [PubMed] [Google Scholar]
  15. Norrby E., Gollmar Y. Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies. Infect Immun. 1975 Feb;11(2):231–239. doi: 10.1128/iai.11.2.231-239.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Norrby E., Lagercrantz R., Gard S., Carlström G. Measles vaccination. 3. Serologic responses to immunization with purified hemagglutinin. Acta Paediatr Scand. 1965 Nov;54(6):581–586. doi: 10.1111/j.1651-2227.1965.tb06422.x. [DOI] [PubMed] [Google Scholar]
  17. Olmsted R. A., Elango N., Prince G. A., Murphy B. R., Johnson P. R., Moss B., Chanock R. M., Collins P. L. Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proc Natl Acad Sci U S A. 1986 Oct;83(19):7462–7466. doi: 10.1073/pnas.83.19.7462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Paterson R. G., Lamb R. A., Moss B., Murphy B. R. Comparison of the relative roles of the F and HN surface glycoproteins of the paramyxovirus simian virus 5 in inducing protective immunity. J Virol. 1987 Jun;61(6):1972–1977. doi: 10.1128/jvi.61.6.1972-1977.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Portner A., Scroggs R. A., Naeve C. W. The fusion glycoprotein of Sendai virus: sequence analysis of an epitope involved in fusion and virus neutralization. Virology. 1987 Apr;157(2):556–559. doi: 10.1016/0042-6822(87)90301-1. [DOI] [PubMed] [Google Scholar]
  20. RAUH L. W., SCHMIDT R. MEASLES IMMUNIZATION WITH KILLED VIRUS VACCINE. SERUM ANTIBODY TITERS AND EXPERIENCE WITH EXPOSURE TO MEASLES EPIDEMIC. Am J Dis Child. 1965 Mar;109:232–237. doi: 10.1001/archpedi.1965.02090020234007. [DOI] [PubMed] [Google Scholar]
  21. Samson A. C., Willcocks M. M., Routledge E. G., Morgan L. A., Toms G. L. A neutralizing monoclonal antibody to respiratory syncytial virus which binds to both F1 and F2 components of the fusion protein. J Gen Virol. 1986 Jul;67(Pt 7):1479–1483. doi: 10.1099/0022-1317-67-7-1479. [DOI] [PubMed] [Google Scholar]
  22. Sheshberadaran H., Norrby E., McCullough K. C., Carpenter W. C., Orvell C. The antigenic relationship between measles, canine distemper and rinderpest viruses studied with monoclonal antibodies. J Gen Virol. 1986 Jul;67(Pt 7):1381–1392. doi: 10.1099/0022-1317-67-7-1381. [DOI] [PubMed] [Google Scholar]
  23. Spriggs M. K., Murphy B. R., Prince G. A., Olmsted R. A., Collins P. L. Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity. J Virol. 1987 Nov;61(11):3416–3423. doi: 10.1128/jvi.61.11.3416-3423.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Toyoda T., Gotoh B., Sakaguchi T., Kida H., Nagai Y. Identification of amino acids relevant to three antigenic determinants on the fusion protein of Newcastle disease virus that are involved in fusion inhibition and neutralization. J Virol. 1988 Nov;62(11):4427–4430. doi: 10.1128/jvi.62.11.4427-4430.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Varsanyi T. M., Morein B., Löve A., Norrby E. Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein. J Virol. 1987 Dec;61(12):3896–3901. doi: 10.1128/jvi.61.12.3896-3901.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Yilma T., Hsu D., Jones L., Owens S., Grubman M., Mebus C., Yamanaka M., Dale B. Protection of cattle against rinderpest with vaccinia virus recombinants expressing the HA or F gene. Science. 1988 Nov 18;242(4881):1058–1061. doi: 10.1126/science.3194758. [DOI] [PubMed] [Google Scholar]
  27. Yoshikawa Y. [Molecular mechanisms of persistent infection of subacute sclerosing panencephalitis (SSPE) viruses]. Uirusu. 1988 Jun;38(1):23–57. doi: 10.2222/jsv.38.23. [DOI] [PubMed] [Google Scholar]
  28. Yusoff K., Nesbit M., McCartney H., Meulemans G., Alexander D. J., Collins M. S., Emmerson P. T., Samson A. C. Location of neutralizing epitopes on the fusion protein of Newcastle disease virus strain Beaudette C. J Gen Virol. 1989 Nov;70(Pt 11):3105–3109. doi: 10.1099/0022-1317-70-11-3105. [DOI] [PubMed] [Google Scholar]
  29. de Vries P., van Binnendijk R. S., van der Marel P., van Wezel A. L., Voorma H. O., Sundquist B., Uytdehaag F. G., Osterhaus A. D. Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice. J Gen Virol. 1988 Mar;69(Pt 3):549–559. doi: 10.1099/0022-1317-69-3-549. [DOI] [PubMed] [Google Scholar]
  30. van Wyke Coelingh K., Tierney E. L. Antigenic and functional organization of human parainfluenza virus type 3 fusion glycoprotein. J Virol. 1989 Jan;63(1):375–382. doi: 10.1128/jvi.63.1.375-382.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES